Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.11.28.691195

Adapting Co-Folding Models for Structure-Based Protein-Protein Docking Through Flow Matching

Abstract

Co-folding models like AlphaFold have revolutionized protein complex structure prediction, yet their reliance on multiple sequence alignments (MSAs) limits their applicability on challenging targets such as antibody-antigen complexes. An alternative approach, structure-based protein-protein docking, predicts the bound complex structure from the unbound monomer structures without requiring MSAs. In this work, we propose a novel method to adapt co-folding models for structure-based protein-protein docking by replacing their template module with a docking module, followed by training end-to-end with a flow-matching objective. We apply our method to AlphaFold-Multimer (AF-M) using the OpenFold implementation and transform it into a generative docking model, which we name AF2Dock. We evaluate AF2Dock and various baseline methods on the PINDER-AF2 benchmark and an antibody/nanobody test set. When using non-holo inputs, AF2Dock shows competitive performance compared to other structure-based docking methods and, in the case of nanobody complexes, outperforms all other docking methods tested here. Although AF2Dock underperforms co-folding AF-M and AF3 in success rates when using non-holo inputs, it produces orthogonal predictions and successfully identifies correct structures for targets where co-folding models fail. Ablation studies confirm that full-parameter fine-tuning of the AF-M components is critical for performance and reveal that, surprisingly, the inclusion of ESM embeddings can hinder success rates in certain cases such as nanobody complexes. The code is available at https://github.com/Graylab/AF2Dock.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Xu, D., Chu, L.-S., Gray, J. J.. 2025-12-01. Adapting Co-Folding Models for Structure-Based Protein-Protein Docking Through Flow Matching. https://doi.org/10.1101/2025.11.28.691195

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Design of colipids with controlled lateral distance of head group moieties for targeting strategies in the field of lipid-based nanoparticles

Lipid nanoparticles and liposomes are nanoparticle drug formulations which are firmly established in clinics. In order to expand their application and improve efficacy, surface modifications can be a key strategy, especially for cell specific targeting. Targeting can be achieved by integrating ligand functionalized lipids or lipidoids on the nanoparticle surface. In this case, not solely the targeting ligand itself, but also the structure of the whole targeting lipid/lipidoid can affect the interaction of the targeting ligand with the binding motive on cells. Especially, distal spacer structures between lipid anchor and ligand unit, often composed of polyethylene glycol chains, provide a certain distance of the ligand from the nanoparticle surface. A concept which is currently neglected is the control of the lateral distance between ligand structures on the nanoparticle. Herein we investigated the possibility to design lipidoids with a lateral spacer composed of polyethylene glycol units. We synthesized and characterized different lipidoids which provide a primary amine in the head group for possible ligand coupling. In our model lipidoids the head groups were functionalized with a paramagnetic probe to apply electron paramagnetic resonance (EPR) methods for the characterization of the lipidoid interaction with model nanoparticles, in our case liposomes. Continuous wave EPR was used to study the efficiency of the novel lipidoids to integrate into lipid bilayers of model liposomes, which was shown to depend on lipidoid structure and liposome composition. Furthermore, using double electron-electron resonance (DEER), we observed lipidoid conformational changes occurring upon integration into liposomes.

biophysics↗

Beyond Sequence and Structure: Pretraining PLMs on Continuous Biophysical Fields

We introduce the Biophysical Transformer, a protein language model that adds continuous biophysical fields as a third pretraining signal beside sequence and structure. A Poisson-Boltzmann solver computes the electrostatic potential around each three-residue token, and the model learns to predict it from sequence alone. A rotationally invariant spherical-harmonic descriptor serves as the loss target, eliminating the need for frame alignment during training and for coordinates at inference. Against a matched, one-flag control on the FLIP Meltome thermostability benchmark, the field objective raises Spearman correlation on every trained head of both human splits.The gain on human survives residualizing dipeptide composition under two architecturally different readouts and survives removing the test proteins that overlap the pretraining corpus. No effect survives on the organism-mixed split. At 1.1M parameters, both the Biophysical Transformer and its sequence-only control exceed FLIP's one-hot CNN and untrained-ESM baselines on every split. All results rest on a single pretraining run per arm,and the current design does not separate field content from generic regularization.

biophysics↗

An auditable harness for biomolecular dynamics simulations by AI agents

AI agents now generate biological hypotheses faster than they can be tested. Hypotheses stated at the atomic level can be examined with molecular dynamics (MD) simulations. For new questions without a reference, trust in an agent-run simulation rests on a tool-written process record, not the agent's account. Existing MD agents leave this record to the language model. Here we present MDClaw, a harness whose validating tools and directed acyclic graph (DAG) check stages before execution and record every simulation stage. On MDDataBench, which grades outputs against deposited simulations, four open-weight models with MDClaw passed all three runs on 81-100% of 31 test systems. The DAG complements this outcome check. An ablation without the DAG revealed 11 successful runs that had skipped minimization or equilibration, or simulated a different structure. MDClaw carried questions from human and AI scientists through simulation to trajectories traceable to their inputs and settings.

biophysics↗